drugset / Trial / NCT01538745
Low Dose Ketamine (LDK) Versus Morphine for Acute Pain Control in the Emergency Department
Phase 4
Completed
45 enrolled
Brooke Army Medical Center
U.S. Air Force Office of the Surgeon General · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to compare the safety and effectiveness of intravenous low dose ketamine (LDK) to the industry standard of morphine (MOR) in regards to controlling acute pain in the emergency department. Both LDK and morphine have side effects. The amount and character of these side effects will be compared. Additionally, the degree of sedation or agitation will be specifically measured. The aim of this current study is to make this comparison and shift the evidence for LDK use from the anecdotal to the scientific.
Timeline
- Start
- 2012-02
- Primary completion
- 2013-03
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.3 mg/kg | Intravenous |
| Comparator | Morphine | Other / unclassified | 0.1 mg/kg | Intravenous |